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Approximately 75,000 chemicals are
currently listed in the U.S. Environmental
Protection Agency (U.S. EPA) Toxic
Substances Control Act Chemical Substances
Inventory (U.S. EPA 2003); however, the
toxic potential and the molecular mecha-
nisms underlying the action of many of
these chemicals are not well understood.
Scientists have long exploited diverse
experimental models to understand the
complexity of gene–environment interac-
tions. With the rising number of pub-
licly available sequences and completely
sequenced genomes, comparative studies are
proving to be essential for elucidating bio-
logical systems (Koonin et al. 2000) and
annotating accumulating genomic and
proteomic data (Whelan et al. 2001).
Comparisons of more distantly related verte-
brate and invertebrate species may be 
of particular value for identifying con-
served genetic and molecular mechanisms
(Wittbrodt et al. 2002). It is on this premise
that the Comparative Toxicogenomics
Database (CTD) is being developed. 
CTD will facilitate comparisons of
sequences and functions of toxicologically
signiﬁcant genes and proteins from diverse
organisms, with an emphasis on aquatic
and mammalian species. The goal is to pro-
vide unique insights into the signiﬁcance of
conserved sequences and polymorphisms,
the genetic basis of variable sensitivity,
molecular evolution, and adaptation. The
potential value of such comparisons is
demonstrated by studies of the aryl hydro-
carbon receptor (AhR) (Hahn 2002;
Thomas et al. 2002), which modulates the
toxic action of the environmental contami-
nant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (Poland and Knutson 1982;
Schmidt and Bradfield 1996). Mammals,
ﬁshes, and aquatic invertebrates exhibit dif-
ferent toxicity profiles (Hahn 2002).
Studies of AhR in these organisms identi-
ﬁed duplication events in ﬁshes and differ-
ences in sequence identity, TCDD-binding
capacity, and activation of downstream tar-
gets (Hahn 2002; Thomas et al. 2002).
Although the physiologic roles of AhR are
still not well understood, correlations
between AhR sequences and functions in
distantly related organisms may provide
valuable information about the evolution-
ary impact on this gene, possible insights
into the genetic basis of toxicity, and
directions for future research. 
There is a strong precedent for compar-
ative studies with aquatic organisms. The
recent sequencing of the pufferfish (Fugu
rubripes) genome has resulted in the discov-
ery of nearly 1,000 human genes not
described previously in the public domain
(Aparicio et al. 2002). The anticipated
sequences for zebrafish (Danio rerio) and
spotted green pufferfish (Tetraodon
nigroviridis) genomes will likely make addi-
tional contributions to the annotation of
the human genome. Evolutionarily diverse
aquatic organisms have become important
models for studying human disease. For
example, membrane transporters that are
the sites of action of diuretic drugs, includ-
ing the bumetanide-sensitive Na-K-Cl
cotransporter and the thiazide-sensitive
NaCl cotransporter, were ﬁrst cloned from
specialized organs in marine species
(Gamba et al. 1993; Xu et al. 1994).
Mutagenesis studies in teleosts have gener-
ated a spectrum of biologically relevant and
nonoverlapping phenotypes (Wittbrodt
et al. 2002). Large-scale genetic screens
have produced more than 500 zebrafish
mutants, many with phenotypes similar to
human disorders (Dooley and Zon 2000).
Medaka (Oryzias latipes) are routinely used
for studies in carcinogenesis and environ-
mental health (Wittbrodt et al. 2002). The
more distantly related elasmobranchs have
provided unique insight into conserved
functional domains of genes associated
with human liver function (Ballatori and
Villalobos 2002; Cai et al. 2001, 2002) and
cystic ﬁbrosis (Aller et al. 1999). 
The growing body of genomic informa-
tion available to the scientific community
has led to an increase in the number and
scope of biological databases. A recent
review (Baxevanis 2002) estimated a total
of 335 existing databases in 2002, an
increase from 281 in 2001. These data-
bases address a range of complex chal-
lenges for biologists, such as managing
comprehensive repositories of genomic
and proteomic data (Benson et al. 2002;
O’Donovan et al. 2002), annotating
species-specific genomes (Blake et al.
2002; Sprague et al. 2001), and identify-
ing protein families and conserved
domains (Baxevanis 2002). Existing toxi-
cology databases have cataloged chemical
and physical properties of toxic agents,
mutagenicity data, environmental health
and regulatory information, ecologic data,
and scientific references (Russom 2002;
Wexler 2001; Young 2002). It is impotant
to note that there is no existing publicly
available resource that provides toxicologic
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The Mount Desert Island Biological Laboratory in Salsbury Cove, Maine, USA, is developing the
Comparative Toxicogenomics Database (CTD), a community-supported genomic resource
devoted to genes and proteins of human toxicologic signiﬁcance. CTD will be the ﬁrst publicly
available database to a) provide annotated associations among genes, proteins, references, and
toxic agents, with a focus on annotating data from aquatic and mammalian organisms; b) include
nucleotide and protein sequences from diverse species; c) offer a range of analysis tools for cus-
tomized comparative studies; and d) provide information to investigators on available molecular
reagents. This combination of features will facilitate cross-species comparisons of toxicologically
signiﬁcant genes and proteins. These comparisons will promote understanding of molecular evo-
lution, the signiﬁcance of conserved sequences, the genetic basis of variable sensitivity to environ-
mental agents, and the complex interactions between the environment and human health. CTD
is currently under development, and the planned scope and functions of the database are
described herein. The intent of this report is to invite community participation in the develop-
ment of CTD to ensure that it will be a valuable resource for environmental health, molecular
biology, and toxicology research. Key words: aquatic, comparative, database, environmental
health, ﬁshes, genomic, health, toxicogenomics, toxicology. Environ Health Perspect 111:793–795
(2003). doi:10.1289/txg.6028 available via http://dx.doi.org/ [Online 13 February 2003]
Toxicogenomics Commentaryannotation of genomic and proteomic
data from diverse species. In addition to
CTD, another public toxicogenomic
database is being developed by the
National Center for Toxicogenomics at
the National Institute of Environmental
Health Sciences (NIEHS). The Chemical
Effects in Biological Systems (CEBS)
Knowledge Base will capture and integrate
global molecular expression data with
pathway and regulatory network informa-
tion related to toxicology and human dis-
ease (Waters et al. 2003). It is the goal of
both development groups that CTD and
CEBS be complementary in focus and
functionally compatible. 
Scope
Biologic features and strategic plan. CTD
is being developed at the Mount Desert
Island Biological Laboratory (MDIBL) in
Salsbury Cove, Maine, USA, in collaboration
with investigators at NIEHS Marine and
Freshwater Biomedical Sciences (MFBS)
centers and other scientists with expertise in
molecular biology, toxicology, and bioinfor-
matics. CTD will include curated informa-
tion about nucleotide and protein sequences,
associated references, toxic agents, reagents,
and taxonomy. Tools for data analysis,
manipulation, and visualization for compara-
tive studies will also be provided. This scope
of features dictates a phased implementation
approach that will combine automated and
manual curation strategies. The first year
(September 2002–August 2003) will include
three implementation phases. 
Phase I will focus on the acquisition
and integration of sequences, references to
the scientific literature, and toxic agents.
Although annotation will focus on genes and
proteins with associated toxicologic data, an
inclusive set of sequence data will be stored
locally in CTD to a) maximize the value of
comparative sequence analyses that may be
performed using integrated computational
tools, b) prevent exclusion of sequences
with potential toxicological significance,
c) allow querying of annotated features, and
d) provide integration with data from other
sources. Subsets of nucleotide sequences will
be acquired from the National Center
for Biotechnology Information (NCBI;
http://www.ncbi.nlm.nih.gov). CTD will store
all nucleotide reference sequences for human
(Homo sapiens), mouse (Mus musculus), rat
(Rattus norvegicus), and fruitﬂy (Drosophila
melanogaster), thereby providing a nonredun-
dant set of sequences for these particular
species (Pruitt and Maglott 2001). All
nucleotide sequences for other vertebrates
and invertebrates will be loaded from
GenBank (http://www.ncbi.nlm.nih.gov/
Sitemap/index.html GenBank; Benson et al.
2002). Protein sequences for the corre-
sponding organisms will be acquired from
SWISS-PROT (http://ca.expasy.org/sprot/),
which provides a comprehensive, annotated,
and nonredundant protein sequence data set
(O’Donovan et al. 2002). Direct submis-
sions of sequence data to CTD will not be
accepted to avoid duplication of informa-
tion loaded from GenBank and SWISS-
PROT. Information will be updated from
these databases frequently to ensure that
CTD remains current and comprehensive.
During phase I, references associated
with genes and proteins will be identified
from GenBank and SWISS-PROT sequence
records and the NCBI literature database
PubMed (http://www.ncbi.nlm.nih.gov/
entrez/query.fcgi?db=PubMed). Candidate
associations between genes, proteins, and
toxic agents will be identiﬁed using queries
to search the titles, abstracts, and Medical
Subject Headings (MeSH) of references
(Lipscomb 2000; Young 2002) included in
CTD. For queries of genes and proteins,
nomenclature inconsistencies will be
accounted for initially by including syn-
onyms identiﬁed in public biologic databases
also addressing this issue, such as Locus Link
(http://www.ncbi.nlm.nih.gov/LocusLink/) and
the Mouse Genome Informatics databases
(http://www.informatics.jax.org/). Queries for
toxic agents will be constructed using a hier-
archical vocabulary that will enhance
MeSH’s Chemicals Index and Chemicals
and Drugs category by supplementing it
with chemical information from the U.S.
EPA, the U.S. Fish and Wildlife Service,
and the National Toxicology Program.
Criteria for queries will be established in col-
laboration with investigators from other
NIEHS MFBS centers and other investiga-
tors from the scientific community with
expertise in molecular biology and toxicology.
All associations between data sets in CTD
will be labeled “not reviewed” until a curator
has conﬁrmed their accuracy. 
During phase II, we will evaluate
and integrate analysis tools for sequence
similarity searches (e.g., WU-BLAST)
(Altschul et al. 1990), multiple alignments
(e.g., ClustalW) (Thompson et al. 1994),
and phylogenetic analysis (e.g., PHYLIP)
(Felsenstein 1993). Currently, many web
sites offer BLAST capabilities against stati-
cally deﬁned data sets that include sequences
from specific organisms, groups of organ-
isms, or databases. These data sets are often
either too inclusive, resulting in an over-
abundance of “hits,” or exclude organisms
of interest. By storing sequences and related
data locally in a relational database, it will be
possible for users to deﬁne customized data
sets. This capability will permit highly
focused sequence analysis, such as restricting
BLAST searches to a speciﬁc combination of
taxa. In addition, large-scale automated
sequence analysis will be possible. 
During phase III, we will develop a
World Wide Web (WWW) interface for
CTD that will include user registration and
comment forms, basic and advanced query
options to access data for sequences, refer-
ences, and toxic agents, and a platform for
analyzing sequences. At the completion of
phase III, CTD will be made accessible to
collaborators and participating members of
the community to evaluate its functionality
and test the system. On the basis of feed-
back from the scientific community, we
will then work with MFBS center investi-
gators in subsequent years to continue the
data curation process and prioritize the
inclusion of additional data sets such as
expressed sequence tags, single nucleotide
polymorphisms, and data from microarray
experiments.
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Figure 1. Software development life cycle. The CTD system will be implemented in stages. A data model
was designed prior to developing functional speciﬁcations and a prototype system. Biologists will evalu-
ate content and functionality throughout the development life cycle. Implementation. CTD is being designed
using a data-driven approach in which the
data model is developed prior to specifying
system functions (Figure 1). This approach
will a) promote reusability of data, b) estab-
lish a consistent set of names and defini-
tions for data, c) determine what functions
the system will support, and d) provide a
concise overview of the system’s scope
(Simsion 1994). CTD will be implemented
in an Oracle relational database. The cur-
rent data model includes 40 entities with
well-documented deﬁnitions, including text
descriptions of all entities and attributes,
data types, constraint deﬁnitions, and repre-
sentative values. CTD will include a cura-
tion tool and WWW user interface. Oracle
Forms Developer will be used to develop
the first generation of the curation tool,
which will be used to annotate and modify
data. This tool is tightly integrated with the
Oracle database and provides client-side
validation, reusable components, and rapid
prototyping capability. The WWW inter-
face will be developed using the Python
programming language.
World Wide Web interface. The CTD
WWW interface will combine the familiar
paradigms of NCBI and Mouse Genome
Informatics databases. Simple and advanced
query forms will be available to retrieve
information about genes, including nucleo-
tide and protein sequences, as well as refer-
ences, toxic agents, reagents, and taxonomy.
Each of these major categories will have a
resource page providing a description of
associated data and links to resources with
supplemental information. Data will be
highly integrated within CTD and with
external databases. 
Community involvement. MDIBL is
committed to involving the scientiﬁc com-
munity in the development of CTD. To
this end, we are formally collaborating with
investigators at each of the NIEHS MFBS
centers; hosting conferences to evaluate the
progress and strategic plan of CTD;
attending national meetings to promote
awareness of and participation in CTD
development; and planning online mecha-
nisms for feedback and data submissions.
From its inception, CTD has benefited
from significant community support. In
April 2000, 45 biologists and bioinformat-
ics experts attended a conference at
MDIBL (MDIBL 2000) to address the
application of bioinformatics in toxicology
research. Discussions at this meeting for-
mulated the initial plan for a toxicoge-
nomics database and were the foundation
for the NIEHS-phased innovation grant
application that now funds CTD. In May
2002 MDIBL hosted a workshop (MDIBL
2002) to promote dialog about genomic
databases in the scientific community and
to seek feedback about the progress of
CTD. Because of the success and utility of
these meetings, another conference is
planned for 2004.
Community Invitation
To ensure that CTD is a valuable resource
for the scientiﬁc community, we invite par-
ticipation in its development. Speciﬁc chal-
lenges for which we encourage feedback
include addressing nomenclature inconsis-
tencies, clustering sequence data from
diverse species, and determining the role of
microarray data in CTD. Defining strate-
gies to meet these challenges will have
broad implications for molecular biologists
and toxicologists. 
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